NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Shanghai Medium Bank Biotechnology

Shanghai Medium Bank Biotechnology

Private
ShanghaiHealthcare & Life Scienceshttps://mediumbank.net/

Last Round

Series B

Apr 15, 2022

Total Funding Raised

$16M

Company Overview

Shanghai Medium Bank Biotechnology is a biotechnology company that develops advanced cell culture medium solutions and provides upstream bioprocessing services for the pharmaceutical industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

cell culture mediabioprocessingCDMOcontract development and manufacturingAOF mediaanimal origin-free mediabiologics manufacturingCHO cell linesmedia optimizationbiotech reagentsspent media analysisbiopharma supplyAI-driven drug discoverylab-grown meat mediabiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Medium Bank Biotechnology Comps

Public and private peers based on sector, stage, and business model.

Shanghai Medium Bank Biotechnology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shanghai Medium Bank Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 15, 2022
Series AJun 26, 2021
Early FundingNov 8, 2020

Key People

Founding team and executive leadership

James H.

Co-Chief Executive Officer

Executive Team

Shanghai Medium Bank Biotechnology Investors

Notable investors and investment history

Shanghai Medium Bank Biotechnology investors
InvestorRounds
Grand Yangtze CapitalEarly Funding

Shanghai Medium Bank Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Medium Bank Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Medium Bank Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range4
Year Founded2019
Last FundingApr 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.